|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/58 | |
| A61K 9/16 | |||
| A61K 47/48 | |||
| A61K 9/10 | |||
| A61K 9/20 |
| (11) | Number of the document | 2428205 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11192711.7 |
| Date of filing the European patent application | 2007-03-15 | |
| (97) | Date of publication of the European application | 2012-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 783181 P | 2006-03-16 | US |
| (72) |
Tu, Yu-hsing, US
Mehta, Ketan, US
|
| (73) |
Tris Pharma, Inc.,
2033 Route 130, Suite D, Monmouth Junction, NJ 08852,
US
|
| (54) | Modified release formulations containing drug-ion exchange resin complexes |
| Modified release formulations containing drug-ion exchange resin complexes |